| Literature DB >> 24250393 |
Somasundaram Jeevanandham1, Duraiswamy Dhachinamoorthi, Kothapalli Bannoth Chandra Sekhar.
Abstract
This study examines the controlled release behavior of both water-soluble (Entities:
Keywords: Caesalpinia pulcherrima; Drug release.; Kernel powder; Natural gums; Polysaccharide
Year: 2011 PMID: 24250393 PMCID: PMC3813039
Source DB: PubMed Journal: Iran J Pharm Res ISSN: 1726-6882 Impact factor: 1.696
Formulations of various Caesalpinia pulcherrima seed polysaccharide matrices
|
|
|
|
|
|---|---|---|---|
| Drug Substancea | 50 | 50/100 | 50 |
| CPSPb | 200 | 0 | 180/160/140/120/100/80 |
| Cross-linked CPSP | 0 | 200 | 0 |
| Lactose/MCc | 0 | 0 | 20/40/60/80/100/120 |
| Magnesium Stearate | 2.5 | 2.5/3 | 2.5 |
aCaffeine/Acetaminophen/Theophylline/Salicylic acid/Indomethacin, bCaesalpinia pulcherrima Seed Polysaccharide (CPSP), cMicrocrystalline Cellulose (MC)
List of model drugs used for preparation of matrix tablet
|
|
|
|
|---|---|---|
| Caffeine anhydrous | 37.0 | 273 |
| Acetaminophen | 18.9 | 242 |
| Theophylline Anhydrous | 9.9 | 271 |
| Salicylic acid | 3.1 | 297 |
| Indomethacin | 0.9 | 318 |
a Phosphate buffer pH 7.2
Variation of n values with mechanism of diffusion
|
|
|
|
|---|---|---|
| 0.5 | Fickian diffusion | t-0.5 |
| 0.5 < n > 1.0 | Anomalous diffusion | tn-1 |
| 1.0 | Case II transport | Zero order |
| n > 1.0 | Super case II transport | tn-1 |
Figure 113C-N.M.R. spectrum of Caesalpinia pulcherrima seed polysaccharide
Figure 2X-ray diffraction pattern of Caesalpinia pulcherrima seed polysaccharide
Figure 3Release profile of drugs of different solubility from CPSP tablets (mean ± SD; n = 3)
The n value of the formulations containing drug type with D : P ratio of 1 : 4 and cross linker with D:P ratio of 1: 2 and 1 : 4
|
|
|
|---|---|
|
| |
| Caffeine | 0.60 |
| Acetaminophen | 0.66 |
| Theophylline | 0.71 |
| Salicylic acid | 0.73 |
| Indomethacin | 0.98 |
|
| |
| (1:2) | 1.24 |
| (1:4) | 1.25 |
Figure 4Effect of replacing CPSP with lactose on release of caffeine (mean ± SD; n = 3).
Figure 5Effect of replacing CPSP with microcrystalline cellulose on release of caffeine (mean ± SD; n = 3).
The n value of formulations containing D : P ratio of 1: 4 when replacing the polymer with different amount of lactose and microcrystalline cellulose
|
|
|
|
|---|---|---|
|
| ||
| 0% | 0.60 | 5.0 |
| 10% | 0.59 | 4.5 |
| 20% | 0.60 | 4.0 |
| 30% | 0.61 | 3.75 |
| 40% | 0.61 | 3.5 |
| 50% | 0.61 | 2.5 |
| 60% | 0.59 | 2.0 |
|
| ||
| 0% | 0.60 | 5.0 |
| 10% | 0.59 | 4.5 |
| 20% | 0.56 | 4.5 |
| 30% | 0.56 | 4.0 |
| 40% | 0.58 | 3.5 |
| 50% | 0.57 | 3.15 |
| 60% | 0.52 | 2.5 |
Figure 6The release profile of acetaminophen from cross linked CPSP tablets (mean ± SD; n = 3).